Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by TScan Therapeutics, Inc.

< Previous 1 2 Next >
TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Announces Upcoming Oral Presentation of Data from the ALLOHA™ Phase 1 Heme Trial at the 66th American Society of Hematology Annual Meeting and Exposition
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 39th Annual Meeting
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics to Participate in Upcoming Investor Conferences
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Announces Updates to its Board of Directors
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Announces Closing of Upsized Public Offering
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 at the 2024 Tandem Meetings of ASTCT and CIBMTR
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M.D., M.S., as Vice President, Clinical Development
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 Tandem Meetings of ASTCT and CIBMTR
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Announces 2024 Clinical Plans and Highlights Recent Progress
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
TScan Therapeutics to Host Virtual KOL Event to Discuss Results from Ongoing Phase 1 Trial of TSC-100 and TSC-101 Presented at the 65th ASH Annual Meeting and Exposition
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.